151 related articles for article (PubMed ID: 8673470)
21. [Molecular basis of Fanconi's anemia].
Digweed M
Klin Padiatr; 1999; 211(4):192-7. PubMed ID: 10472548
[TBL] [Abstract][Full Text] [Related]
22. Developmental expression of the Fac gene correlates with congenital defects in Fanconi anemia patients.
Krasnoshtein F; Buchwald M
Hum Mol Genet; 1996 Jan; 5(1):85-93. PubMed ID: 8789444
[TBL] [Abstract][Full Text] [Related]
23. The Fanconi anemia polypeptide FACC is localized to the cytoplasm.
Yamashita T; Barber DL; Zhu Y; Wu N; D'Andrea AD
Proc Natl Acad Sci U S A; 1994 Jul; 91(14):6712-6. PubMed ID: 7517562
[TBL] [Abstract][Full Text] [Related]
24. Induction of Fanconi anemia cellular phenotype in human 293 cells by overexpression of a mutant FAC allele.
Youssoufian H; Li Y; Martin ME; Buchwald M
J Clin Invest; 1996 Feb; 97(4):957-62. PubMed ID: 8613549
[TBL] [Abstract][Full Text] [Related]
25. The effect of the Fanconi anemia polypeptide, FAC, upon p53 induction and G2 checkpoint regulation.
Kupfer GM; D'Andrea AD
Blood; 1996 Aug; 88(3):1019-25. PubMed ID: 8704210
[TBL] [Abstract][Full Text] [Related]
26. The Fanconi anemia polypeptide, FAC, binds to the cyclin-dependent kinase, cdc2.
Kupfer GM; Yamashita T; Naf D; Suliman A; Asano S; D'Andrea AD
Blood; 1997 Aug; 90(3):1047-54. PubMed ID: 9242535
[TBL] [Abstract][Full Text] [Related]
27. Cytoplasmic localization of FAC is essential for the correction of a prerepair defect in Fanconi anemia group C cells.
Youssoufian H
J Clin Invest; 1996 May; 97(9):2003-10. PubMed ID: 8621788
[TBL] [Abstract][Full Text] [Related]
28. Fanconi anemia C gene product regulates expression of genes involved in differentiation and inflammation.
Zanier R; Briot D; Dugas du Villard JA; Sarasin A; Rosselli F
Oncogene; 2004 Jun; 23(29):5004-13. PubMed ID: 15077170
[TBL] [Abstract][Full Text] [Related]
29. Damage-resistant DNA synthesis in Fanconi anemia cells treated with a DNA cross-linking agent.
Centurion SA; Kuo HR; Lambert WC
Exp Cell Res; 2000 Nov; 260(2):216-21. PubMed ID: 11035916
[TBL] [Abstract][Full Text] [Related]
30. Development and characterization of immortalized fibroblastoid cell lines from an FA(C) mouse model.
Tomkins DJ; Care M; Carreau M; Buchwald M
Mutat Res; 1998 Jul; 408(1):27-35. PubMed ID: 9678061
[TBL] [Abstract][Full Text] [Related]
31. 3R coordination by Fanconi anemia proteins.
Macé G; Bogliolo M; Guervilly JH; Dugas du Villard JA; Rosselli F
Biochimie; 2005 Jul; 87(7):647-58. PubMed ID: 15935541
[TBL] [Abstract][Full Text] [Related]
32. Sequence variations in the Fanconi anaemia gene, FAC: pathogenicity of 1806insA and R548X and recognition of D195V as a polymorphic variant.
Lo ten Foe JR; Barel MT; Thuss P; Digweed M; Arwert F; Joenje H
Hum Genet; 1996 Nov; 98(5):522-3. PubMed ID: 8882868
[TBL] [Abstract][Full Text] [Related]
33. The fanconi anemia pathway requires FAA phosphorylation and FAA/FAC nuclear accumulation.
Yamashita T; Kupfer GM; Naf D; Suliman A; Joenje H; Asano S; D'Andrea AD
Proc Natl Acad Sci U S A; 1998 Oct; 95(22):13085-90. PubMed ID: 9789045
[TBL] [Abstract][Full Text] [Related]
34. Inactivation of the Fanconi anemia group C gene augments interferon-gamma-induced apoptotic responses in hematopoietic cells.
Rathbun RK; Faulkner GR; Ostroski MH; Christianson TA; Hughes G; Jones G; Cahn R; Maziarz R; Royle G; Keeble W; Heinrich MC; Grompe M; Tower PA; Bagby GC
Blood; 1997 Aug; 90(3):974-85. PubMed ID: 9242526
[TBL] [Abstract][Full Text] [Related]
35. The Fanconi anemia group C gene product modulates apoptotic responses to tumor necrosis factor-alpha and Fas ligand but does not suppress expression of receptors of the tumor necrosis factor receptor superfamily.
Koh PS; Hughes GC; Faulkner GR; Keeble WW; Bagby GC
Exp Hematol; 1999 Jan; 27(1):1-8. PubMed ID: 9923438
[TBL] [Abstract][Full Text] [Related]
36. Functional correction of FA-C cells with FANCC suppresses the expression of interferon gamma-inducible genes.
Fagerlie SR; Diaz J; Christianson TA; McCartan K; Keeble W; Faulkner GR; Bagby GC
Blood; 2001 May; 97(10):3017-24. PubMed ID: 11342426
[TBL] [Abstract][Full Text] [Related]
37. Germ cell defects and hematopoietic hypersensitivity to gamma-interferon in mice with a targeted disruption of the Fanconi anemia C gene.
Whitney MA; Royle G; Low MJ; Kelly MA; Axthelm MK; Reifsteck C; Olson S; Braun RE; Heinrich MC; Rathbun RK; Bagby GC; Grompe M
Blood; 1996 Jul; 88(1):49-58. PubMed ID: 8704201
[TBL] [Abstract][Full Text] [Related]
38. A patient-derived mutant form of the Fanconi anemia protein, FANCA, is defective in nuclear accumulation.
Kupfer G; Naf D; Garcia-Higuera I; Wasik J; Cheng A; Yamashita T; Tipping A; Morgan N; Mathew CG; D'Andrea AD
Exp Hematol; 1999 Apr; 27(4):587-93. PubMed ID: 10210316
[TBL] [Abstract][Full Text] [Related]
39. Subtyping analysis of Fanconi anemia by immunoblotting and retroviral gene transfer.
Pulsipher M; Kupfer GM; Naf D; Suliman A; Lee JS; Jakobs P; Grompe M; Joenje H; Sieff C; Guinan E; Mulligan R; D'Andrea AD
Mol Med; 1998 Jul; 4(7):468-79. PubMed ID: 9713825
[TBL] [Abstract][Full Text] [Related]
40. Complementation group assignments in Fanconi anemia fibroblast cell lines from North America.
Jakobs PM; Fiddler-Odell E; Reifsteck C; Olson S; Moses RE; Grompe M
Somat Cell Mol Genet; 1997 Jan; 23(1):1-7. PubMed ID: 9217996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
